 |
Code of Federal Regulations (Last Updated: May 6, 2024) |
 |
Title 21 - Food and Drugs |
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
SubChapter E - Animal Drugs, Feeds, and Related Products |
|
Part 556 - Tolerances for Residues of New Animal Drugs in Food |
|
Subpart B - Specific Tolerances for Residues of New Animal Drugs |
§ 556.226 - Enrofloxacin.
Latest version.
-
§ 556.226 Enrofloxacin.
(a) Acceptable daily intake (ADI). The ADI for total residue of enrofloxacin is 3 µg/kg of body weight per day.
(b) Tolerances. The tolerances for enrofloxacin are:
(1) Cattle. Liver (target tissue): 0.1 ppm desethylene ciprofloxacin (marker residue).
(2) Swine. Liver (target tissue): 0.5 ppm enrofloxacin (marker residue).
(c) Related conditions of use. See § §§ 516.812 and 522.812 of this chapter.
[84 FR 32993, July 11, 2019, as amended at 86 FR 13188, Mar. 8, 2021]